Infection with B. burgdorferi s.l., and the CNS demyelinating disease

Neuroendocrinology Letters

Volumn 32, Issue 4, 2011, Pages 411-414

  Ďurovská, Judita ^a   Bazovská, Sylvia ^a   Pancák, Jaroslav ^a   Záborská, Magdaléna ^a   Derdáková, Markéta ^b   Traubner, Pavel ^a  

^a Bratislava   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

B. burgdorferi infection; CNS demyelinating disease; Positive PCR

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BORRELIA BURGDORFERI; BORRELIA GARINII; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATING DISEASE; DNA DETERMINATION; FEMALE; HUMAN; LABORATORY TEST; LYME DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION;

EID: 80053472271     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role infection. Ann Neurol. 4: 288-299. (Pubitemid 46676728)
2. Bazovská S, Guryčová D, Výrosteková V, et al. (2010) Protilátky proti pôvodcom niektorých prírodne ohniskových nákaz v sérach darcov krvi zo západného Slovenska. Epidem Microbiol Immunol. 4: 168-171.
3. Bojar M (1996) Lymeská borrelióza. Praha, Maxdorf/Jessenius, 224 s.
4. Halperin JJ, Volkman DJ, Wu P (1991) Central Nervous System Abnormalities in Lyme nerouboreliosis. Neurology. 41: 1571-1582.
5. Halperin JJ, Golightly M (1992) Lyme borreliosis in Bels palsy. Neurology. 42: 1268-1270.
6. Hartmann M, Pfadenhauer K (2003) Intrathecal antibody production against Borrelia burgdorferi in a patient with relapsing-remitting multiple sclerosis. Europ J Neurol. 10: 747-748. (Pubitemid 38030894)
7. Honegr K, Hulínská D, Dostál V, et al. (2001) Perzistence Borrelia burgdorferi sensu lato u pacientu s lymeskou boreliózou. Epidem Microbiol Immunol. 50: 10-16. (Pubitemid 32899014)
8. Jayasri Das Sarma (2010) A Mechanism of Virus-Induced Demyelinisation. Interdiscip. Pespect Infect Dis. 10: 1-35.
9. Moravcová L, Plícha D, Vaňousová D, Hercogová J (2009) Prukaz boreliové DNA u pacientu s neuroboreliózou a erthema migrans. Klin mikrobiol infek. lek. 5: 159-164.
10. Pachner AR (1989) Neurologie manifestation of Lyme disease, the "new imitátor". Rev. Infect. Dis. 6: 1482-1486.
11. Plícha D, Moravcová L, Holečková D, et al. (2008) Examination of specific DNA by PCR in patients with different forms of Lyme borreliosis. Int J Dermatol. 47: 1004-1010.
12. Pohl D (2009) Epstein-Barr virus and multiple sclerosis. J Neurol Sci. 286: 62-64.
13. Reik LJ (1991) Lyme Disease and the Nervous System. Thieme Medical Publishers, New York. 338: 128-129.
14. Smetanova K, Burri C, Peréz D, Gern L, Kocianová E (2007) Detection and identification of Borrelia burgdorferi sensu lato genospecies in ticks from three different region in Slovakia. Wien Klin Wochenschr. 119: 17-18, 534-537.
15. Schmutzhard E (2002) Multiple sclerosis and Lyme borreliosis. Wien Klin Wochenschr. 114: 539-543.
16. Staines DR (2008) Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides? Med Hypothesis. 70: 413-418.
17. Strle F, Ruzič-Sabljič J, Cimperman S, et al. (2006) Comparison of Findings for Patients with Borrelia garinii and Borrelia afzelii Isolated from Cerebrospinal Fluid. Clin Infect Dis. 43: 704-10. (Pubitemid 44330732)